Neupogen Injection, Solution
Product Images NDC 55513-546

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Neupogen (NDC 55513-546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neupogen 01

Illustration of a prefilled syringe for NEUPOGEN injection, solution, showing labeled parts including the plunger rod, finger grip, label with expiration date, orange safety guard, syringe barrel, medicine window with markings, and gray needle cap.*

FDA Label Image

Neupogen 02

An instructional diagram of a Neupogen (filgrastim) injection syringe with labeled parts including the used plunger rod, extended orange safety guard, and gray needle cap removed, illustrating components before administration.*

FDA Label Image

Guide To Parts (Before use.)

Instructional illustration showing a hand holding a prefilled syringe labeled NEUPOGEN (Filgrastim) injection. Red arrows indicate to grab the orange safety guard attached to the syringe, demonstrating part of the medication preparation or safety procedure.*

FDA Label Image

Guide To Parts (After use.)

An illustration of a prefilled syringe for NEUPOGEN (filgrastim) injection. The syringe features a label with expiration date, a medicine window with measurement markings, and a gray needle cap.*

FDA Label Image

Open The Tray By Peeling Away The Cover. Grab The Orange Safety Guard To Remove The Prefilled Syringe From The Tray. (Neupogen 05)

An instructional illustration showing medical waste disposal. It includes a filled syringe with orange liquid, three white round tablets, a small folded paper or packet, a beige adhesive bandage, and a red biohazard sharps container with an open lid.*

FDA Label Image

Inspect The Medicine And Prefilled Syringe. (Neupogen 06)

An instructional anatomical illustration depicting recommended injection sites on the human body. Highlighted areas include the upper arm, stomach area (abdomen), and thigh, indicating possible locations for subcutaneous administration of medication such as NEUPOGEN (Filgrastim) injection.*

FDA Label Image

Prefilled Syringe (Neupogen 07)

An anatomical diagram showing recommended injection sites for NEUPOGEN (Filgrastim) injection solution. The injection sites are labeled on the upper arm and buttocks areas of a human figure seen from the back.*

FDA Label Image

Alcohol Wipe, Cotton Ball Or Gauze Pad, Adhesive Bandage, Sharps Disposal Container (Neupogen 08)

An instructional illustration showing a person removing a needle cap from a syringe barrel. A smaller inset shows the disposal of the needle cap into a red biohazard sharps container. The image is intended to demonstrate proper needle safety and disposal technique.*

FDA Label Image

Prepare And Clean Your Injection Site. (Neupogen 09)

FDA Label Image

Hold The Pinch. Insert The Needle Into The Skin At 45 To 90 Degrees. (Neupogen 10)

An instructional illustration showing a person holding a syringe filled with an orange solution. One hand holds the syringe barrel while the other hand holds the plunger, demonstrating a step in preparing or administering an injection.*

FDA Label Image

Using Slow And Constant Pressure, Push The Plunger Rod Until It Reaches The Bottom. (Neupogen 11)

Illustration showing a hand holding a prefilled NEUPOGEN (Filgrastim) injection syringe and removing the protective needle cap by pulling it straight off. The diagram demonstrates part of the preparation process for intravenous or subcutaneous injection.*

FDA Label Image

Stop Before You Finish! (Neupogen 12)

An instructional illustration showing a medication syringe with a plunger labeled 'Plunger to prescribed dose.' The image highlights the plunger mechanism for accurate dosing of an injectable medication, without specifying the product name or dosage.*

FDA Label Image

For Your Safety, Pull The Orange Safety Guard Until It Clicks And Covers The Needle. (Neupogen 13)

An instructional illustration demonstrating how to pinch the skin on the abdomen in preparation for a subcutaneous injection. The image shows fingers grasping the skin near the navel with arrows indicating the pinching motion.*

FDA Label Image

Put The Used Prefilled Syringe In A Fda-cleared Sharps Disposal Container Right Away After Use. Do Not Throw Away (dispose Of) The Prefilled Syringe In Your Household Trash. (Neupogen 14)

An instructional diagram depicting the proper needle insertion angle for an injection. It shows a hand holding a syringe inserted into skin at a 45-degree angle, with an inset displaying a right angle (90 degrees) and a 45-degree angle, indicating the recommended injection angle.*

FDA Label Image

Vial Disposable Syringe And Needle 2 Alcohol Wipes Cotton Ball Or Gauze Pad Adhesive Bandage Sharps Disposal Container (Neupogen 15)

An instructional illustration showing a hand holding a syringe with an orange cap, positioned above the skin of an arm, indicating the injection process. The image demonstrates how to administer the NEUPOGEN injection subcutaneously.*

FDA Label Image

Take The Cap Off The Vial. (Neupogen 16)

FDA Label Image

Clean The Rubber Stopper With One Alcohol Wipe. (Neupogen 17)

Instructional illustration showing how to properly hold and prepare a syringe by gripping the plunger area, with an upward arrow indicating the direction to pull. Red arrows and text emphasize the correct holding point labeled 'GRAB HERE.'*

FDA Label Image

Hold The Syringe By The Barrel With The Needle Cap Pointing Up. Carefully Pull The Needle Cap Straight Off And Away From Your Body. (Neupogen 18)

Instructional illustration showing a hand disposing of a syringe containing an orange liquid into a red biohazard sharps container with a flip-top lid. The image demonstrates safe disposal of injection needles or syringes to prevent contamination or injury.*

FDA Label Image

Important: Throw The Needle Cap Into The Sharps Disposal Container. (Neupogen 19)

Illustration showing components for using a vial and disposable syringe: a vial, needle cap, syringe barrel with measurement markings, plunger, two tablets, two adhesive bandages, and a red biohazard sharps disposal container with an open lid.*

FDA Label Image

Put Your Used Syringes, Needles, And Vials In A Fda-cleared Sharps Disposal Container Right Away After Use. Do Not Throw Away (dispose Of) Needles, Syringes And Vials In Your Household Trash. (Neupogen 20)

An illustration showing a hand holding a vial, likely demonstrating how to grip or handle an injectable medication vial. The vial has a capped top and is held between the thumb and fingers.*

FDA Label Image

Ndc 55513-530-10 10 – 1 mL Single Dose Vials Amgen® Neupogen® (filgrastim) For Injection A Recombinant Granulocyte Colony Stimulating Factor (rg-csf) Derived From E Coli 300 Mcg 300 Mcg/1 mL (3 X 107 Units/1 mL) For Subcutaneous Or Intravenous Use Only Sterile Solution – No Preservative Refrigerate At 2 To 8c (36 To 46f). Avoid Shaking. Amgen Inc. Thousand Oaks, Ca 91320 U.s.a. U.s. License No. 1080 (Neupogen 21)

An instructional illustration showing a person removing a protective cap from the top of a vial, demonstrating the initial step in preparing an injection solution.*

FDA Label Image

Neupogen 21a

Illustration showing a hand removing the protective cap from a syringe, indicating preparation for injection. The syringe is marked with measurement lines, held by another hand, demonstrating safe handling before use.*

FDA Label Image

Ndc 55513-546-10 10 – 1.6 mL Single Dose Vials Amgen® Neupogen® (filgrastim) For Injection A Recombinant Granulocyte Colony Stimulating Factor (rg-csf) Derived From E Coli 480 Mcg 480 Mcg/1.6 mL 300 Mcg/1 mL (3 X 107 Units/1 mL) For Subcutaneous Or Intravenous Use Only Sterile Solution – No Preservative Refrigerate At 2 To 8c (36 To 46f). Avoid Shaking. Amgen Inc. Thousand Oaks, Ca 91320 U.s.a. U.s. License No. 1080 (Neupogen 22)

An instructional illustration showing a hand disposing of a syringe or small vial into a red sharps disposal container marked with a biohazard symbol, with an arrow indicating the action of placing the item inside.*

FDA Label Image

Ndc 55513-924-91 1 X 300 Mcg/0.5 mL Single Dose Prefilled Syringe With 27 Gauge Needle Amgen® Neupogen® Singleject® (filgrastim) Injection A Recombinant Granulocyte Colony Stimulating Factor (rg-csf) Derived From E Coli 300 Mcg Single Dose Prefilled Syringe With 27 Gauge Needle 300 Mcg/0.5 mL For Subcutaneous Use Only This Product Contains Dry Natural Rubber Sterile Solution – No Preservative Refrigerate At 2 To 8c (36 To 46f). Avoid Shaking. Rx Only Manufactured By Amgen Inc. Thousand Oaks, Ca 91320 U.s.a. (Neupogen 23)

Illustration showing the preparation of an injection by drawing solution from a vial with a syringe. One hand holds the vial steady while the other hand inserts the syringe needle into the vial's rubber stopper, with a black arrow indicating downward motion. This diagram is consistent with instructions for NEUPOGEN (filgrastim) injection, solution.*

FDA Label Image

Ndc 55513-924-10 10 X 300 Mcg/0.5 mL Single Dose Prefilled Syringes With 27 Gauge Needles Amgen® Neupogen® Singleject® (filgrastim) Injection A Recombinant Granulocyte Colony Stimulating Factor (rg-csf) Derived From E Coli 300 Mcg Single Dose Prefilled Syringes With 27 Gauge Needles 300 Mcg/0.5 mL For Subcutaneous Use Only This Product Contains Dry Natural Rubber Sterile Solution – No Preservative Refrigerate At 2 To 8c (36 To 46f). Avoid Shaking. Rx Only Manufactured By Amgen Inc. Thousand Oaks, Ca 91320 U.s.a. U.s. License No. 1080 (Neupogen 24)

An instructional illustration showing hands drawing a liquid medication from a vial using a syringe. The image demonstrates the preparation of an injection, likely related to the drug Neupogen (filgrastim), given the context, but no specific product labeling is visible in the image.*

FDA Label Image

Ndc 55513-209-91 1 X 480 Mcg/0.8 mL Single Dose Prefilled Syringe With 27 Gauge Needle Amgen® Neupogen® Singleject® (filgrastim) Injection A Recombinant Granulocyte Colony Stimulating Factor (rg-csf) Derived From E Coli 480 Mcg Single Dose Prefilled Syringe With 27 Gauge Needle 480 Mcg/0.8 mL For Subcutaneous Use Only This Product Contains Dry Natural Rubber Sterile Solution – No Preservative Refrigerate At 2 To 8c (36 To 46f). Avoid Shaking. Rx Only Manufactured By Amgen Inc. Thousand Oaks, Ca 91320 U.s.a. (Neupogen 25)

An instructional illustration showing two hands preparing an injection. One hand holds a vial upside down with a syringe inserted to withdraw liquid, while the other hand is adjusting the syringe plunger. The diagram demonstrates the preparation technique for injectable medication.*

FDA Label Image

Ndc 55513-209-10 10 X 480 Mcg/0.8 mL Single Dose Prefilled Syringes With 27 Gauge Needles Amgen® Neupogen® Singleject® (filgrastim) Injection A Recombinant Granulocyte Colony Stimulating Factor (rg-csf) Derived From E Coli 480 Mcg Single Dose Prefilled Syringes With 27 Gauge Needles 480 Mcg/0.8 mL For Subcutaneous Use Only This Product Contains Dry Natural Rubber Sterile Solution – No Preservative Refrigerate At 2 To 8c (36 To 46f). Avoid Shaking. Rx Only Manufactured By Amgen Inc. Thousand Oaks, Ca 91320 U.s.a. U.s. License No. 1080 (Neupogen 26)

An instructional anatomical illustration showing recommended injection sites for a medication, highlighting the upper arm, stomach area (abdomen), and thigh as suitable locations for subcutaneous or intravenous injections.*

FDA Label Image

Neupogen 27

An illustration showing recommended injection sites for NEUPOGEN (Filgrastim) solution. The diagram highlights the upper arm and buttocks as preferred subcutaneous injection locations on a simplified human figure viewed from the back.*

FDA Label Image

Neupogen 28

An instructional diagram showing a person pinching the skin around the abdomen area, demonstrating a technique for subcutaneous injection likely relevant for NEUPOGEN (Filgrastim) injection administration.*

FDA Label Image

Neupogen 29

An instructional illustration demonstrating how to properly administer an injection using a syringe. The image shows one hand holding the syringe at a 90-degree angle to the skin, with the needle being inserted downward. A 45-degree angle diagram is also depicted for reference.*

FDA Label Image

Neupogen 30

An instructional illustration showing a hand holding a syringe being inserted into the skin of another person's arm, indicating the action for subcutaneous injection administration.*

FDA Label Image

Neupogen 31

An instructional illustration showing a hand disposing of a used syringe into a red biohazard sharps container. The syringe is being held above the container opening, with an arrow indicating the syringe is to be inserted inside the container for proper disposal.*

FDA Label Image

Neupogen 32

NEUPOGEN (filgrastim) injection, 300 mcg per 1 mL solution, in 10 single-dose vials. Label shows the product as a sterile solution for subcutaneous or intravenous use, manufactured by Amgen, Inc. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) and to avoid shaking. The package includes a barcode and indicates no preservative in the solution.*

FDA Label Image

Neupogen 33

NEUPOGEN 480 mcg/1.6 mL injection solution label by Amgen, Inc. The label is for 10 single-dose vials, each containing 480 mcg filgrastim in 1.6 mL. It is a sterile, preservative-free solution for subcutaneous or intravenous use. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) with a caution to avoid shaking.*

FDA Label Image

Neupogen 34

NEUPOGEN 300 mcg/0.5 mL injection solution label with filgrastim as the active ingredient. The label indicates single dose prefilled syringes with 27 gauge needles, intended for subcutaneous use. The product is manufactured by Amgen, Inc. and contains a sterile solution with no preservative. Storage instructions are also provided on the label.*

FDA Label Image

Neupogen 35

Label for NEUPOGEN (filgrastim) injection, a single dose prefilled syringe containing 300 mcg/0.5 mL with a 27 gauge needle. The label indicates refrigerated storage at 2°C to 8°C and use for subcutaneous injection only. Manufactured by Amgen Inc, Thousand Oaks, CA.*

FDA Label Image

Neupogen 36

NEUPOGEN SingleJect filgrastim injection packaging label for single-dose prefilled syringes with 27 gauge needles. The label indicates a strength of 480 mcg/0.8 mL and specifies that the product is for subcutaneous use only. Manufactured by Amgen Inc, the label also notes storage requirements and that the solution is sterile with no preservatives.*

FDA Label Image

Neupogen 37

NEUPOGEN SingleJect (filgrastim) injection 480 mcg/0.8 mL in a single dose prefilled syringe with 27 gauge needle. The label indicates it is a sterile solution for subcutaneous use only and contains dry natural rubber. Manufactured by Amgen, Inc., Thousand Oaks, CA. Storage recommended at 2°C to 8°C (36°F to 46°F) with avoidance of shaking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.